I hold shares in ATHJF being TD Ameritrade does not trade on ASX. Trading on ATHJF has picked up 10+ fold in the last couple days. The thinking that the USA heavyweights aren't interested until 2b is underway is for the most part correct. It is obviously no secret to USA Pharma that CD49d will hold a signifigant key to inflammation and also dystrophin. Will there be any connection to 1102 and a decrease in cardiomyothapy. Think about it for one second if there is found a link between ATL 1102, fixing the dystrophin mutation and a related decrease in cardiomyopathy. I know I'm putting the cart before the proverbial horse here but this link is possible. We need AEI to accomplish this even if they flip stock we couldn't have gotten to this point without them.
USA ANP, page-32
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
-0.001(1.25%) |
Mkt cap ! $83.73M | |||
| Open | High | Low | Value | Volume |
| 8.1¢ | 8.2¢ | 7.9¢ | $153.8K | 1.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 927041 | 7.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.1¢ | 218878 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| PER (ASX) Chart |